1 3 3 1 a r t I C l e S The visceral (or autonomic) motor system controls involuntary functions that are regulated by the activity of smooth muscle fibers, cardiac muscle fibers and glands. The two major divisions include the sympathetic and parasympathetic systems. The control of both divisions is modulated by inputs from the hypothalamus to preganglionic neurons in the brainstem and spinal cord, which in turn determine the activity of the primary visceral motor neurons in autonomic ganglia. This circuit allows the maintenance of physiological balance of bodily functions and it is critically involved in regulating our daily living activities, such as exercise, standing up, meal ingestion adjustments, thermal regulation and more 1,2 . Although these divisions are active all the time at some level, the appearance of a stressor results in an increased activity of the sympathetic system, which mobilizes the 'fight or flight' response 1,2 .
The visceral (or autonomic) motor system controls involuntary functions that are regulated by the activity of smooth muscle fibers, cardiac muscle fibers and glands. The two major divisions include the sympathetic and parasympathetic systems. The control of both divisions is modulated by inputs from the hypothalamus to preganglionic neurons in the brainstem and spinal cord, which in turn determine the activity of the primary visceral motor neurons in autonomic ganglia. This circuit allows the maintenance of physiological balance of bodily functions and it is critically involved in regulating our daily living activities, such as exercise, standing up, meal ingestion adjustments, thermal regulation and more 1,2 . Although these divisions are active all the time at some level, the appearance of a stressor results in an increased activity of the sympathetic system, which mobilizes the 'fight or flight' response 1,2 .
The autonomic system 3 has long been considered to be largely nonspecific, as formulated in the Selye's doctrine of nonspecificity, defining that elements involved in autonomic responses are shared regardless of the nature of the demand or stressor 4 . However, more recent studies have suggested a greater degree of specificity in response, which results in varying levels of recruitment of parts of sympathetic noradrenergic and adrenergic components 2, 5, 6 . In particular, there is growing evidence that the outgoing sympathetic response is not one common signal, but can be highly specific, with distinct activities at different target organs. Furthermore, this selectivity seems to depend on the nature of the stressor or stimulus. Examples of this include thermoregulation by activity of sympathetic neurons selectively targeting sweat glands 7, 8 , selective vasoconstriction in muscle, but not cutaneous, blood vessels (BVs) when standing up 7 , and conversely selective increase of intense cutaneous vasoconstriction, pilo-erection (goose bumps) and nipple erection during hypothermia 7, 9 . In addition, nipple-and pilo-erection follow emotional arousal and mechanical stimuli, such as suckling during breast-feeding [10] [11] [12] .
In the nipple-areola complex, contractility and erection are thought to be regulated by sympathetic innervation of the mammary longitudinal and horizontal smooth muscles 13 , whereas pilo-erection is mediated by innervation of smooth muscles attached to hair follicles 14 . Thus, the diverse functions need somehow to be controlled by separate groups of motor neurons.
Immunohistochemical approaches combined with retrograde tracing analyses have provided convergent evidence supporting the existence of some degree of specificity in connectivity of peripheral sympathetic pathways [15] [16] [17] [18] . Although previous analyses have provided considerable insight into the sympathetic system, the results have been confined to studies of function at a defined target organ(s) or a limited number of markers in the ganglia, and have lacked the precision needed to fully uncover molecular types of neurons at a systems level. Thus, it is not fully clear whether cell-type specificity is a basis for governing selective autonomic functions. We therefore established the transcriptome of the stellate and thoracic sympathetic autonomic system at the single cell level for unbiased identification of cell types, supplemented with detailed information on specific gene expression at the individual cell level. Our results reveal the existence of several unique cell types that likely represent discrete outflow channels, including dedicated neurons controlling nipple-and pilo-erection. Focusing on these, we delineated the developmental mechanisms responsible for creating functional diversity.
1 3 3 2 VOLUME 19 | NUMBER 10 | OCTOBER 2016 nature neurOSCIenCe a r t I C l e S RESULTS Organisation of sympathetic neurons into specialized types As an unbiased and comprehensive method for identifying sympathetic cell types, we performed single-cell RNA-sequencing on the mouse postnatal day (P) 27-33 stellate and thoracic sympathetic ganglia (SG) (Fig. 1a and Supplementary Fig. 1a-d) . We analyzed the 298 neuronal cells by first clustering them into cell types using the BackSPIN algorithm 19 (Supplementary Tables 1 and 2 ) and visualized the results using a heat map (Fig. 1b) . We used bi-dimensional t-distributed stochastic neighbor embedding (t-SNE) projection 20 to visualize the relationship between single cells. Cells with similar molecular profiles are grouped together, whereas dissimilar cells are represented as distant points (Fig. 1c) . The overall similarities between the cell types were quantified and their relation shown using (e) The binarized expression of transcription factors. Rectangles are drawn next to single or multiple cell types to represent binary patterns of expression. For each pattern, the names of genes expressed at posterior probability >99% level above baseline are indicated ( Supplementary Fig. 1e-g ).
(f) Violin plots showing the expression of key genes. The violin plots represent the distribution of mRNA molecules in a linear scale. Gray boxes are drawn where gene expression is above basal expression. Dark and light represents high and low levels of expression, respectively (Online Methods).
(g) Combinatorial immunohistochemistry approach for identifying and quantifying neuronal types. NA1-5 neurons all expressed Th and Dbh; ACh1-2 expressed Slc18a3 (VACHT). NA1 was identified by RARRES1 and NA2 neurons were RET + and NPY + (arrowheads), whereas NA3 were NPY + RET − (arrows). NA4 were GFRA2 + ENC1 + VIP − (arrowhead), whereas NA5 were GFRA2 + ENC1 − VIP − (arrowhead). Cholinergic ACh1 and ACh2 groups were identified by VIP expression and ACh2 (arrowhead) were distinguished from ACh1 (arrow) by expression of SST (n = 3). (h) Schematic representation of neuronal types (for full set of markers, see Supplementary Fig. 2a ), their average soma size (in µm 2 ), and proportion in the stellate and sympathetic chain thoracic level (Tho) 1-4 and Tho 5-12 ganglia. n = 3, data are presented as mean ± s.e.m. (i) NA2, NA4 and NA5 neurons were identified by combined TRKA and Ret CFP+ expression (arrowheads) in Ret CFP adult animals. Cholinergic neurons are Ret CFP+ TRKA − (arrow). (j) Ret CFP+ TRKA + (NA2 and NA4-5) neurons expressed Ret at significantly lower levels than Ret CFP+ TRKA − (cholinergic) neurons (t(4) = 3.275, P = 0.0306, unpaired t test, n = 3). Data are presented as mean ± s.e.m. Scale bars represent 10 µm (g) and 20 µm (i). *P ≤ 0.05. a r t I C l e S hierarchical clustering (Fig. 1d) . We determined both unique markers and genes whose expression was specific for any given combination of cell types (Online Methods, Fig. 1f and Supplementary Table 3) . Based on these analyses, we identified five subtypes of noradrenergic neurons (NA1-5), expressing Th and Ntrk1 (TRKA); two subtypes of cholinergic neurons (ACh1, ACh2), expressing Slc18a3 (VACHT); and a glutamatergic (Glut) group, expressing Slc17a6 (VGLUT2). The glutamatergic type was most distant in hierarchical clustering. It exhibited several characteristics of primary sensory neurons, including expression of Slc17a6 (VGLUT2), Tac1 (substance P), Calca (CGRP) and Isl2. Analysis of tissue sections confirmed that this cell type likely represents sensory neurons coalesced, but not intermingled, with sympathetic cells and was therefore excluded from further analysis ( Supplementary Fig. 2a,b,s,t) . We reduced gene expression to a binary code (Online Methods) and interrogated the cell types on the basis of three classes of molecules: transcription factors, receptors and neuropeptides ( Fig. 1e and Supplementary Fig. 1e-h ). Transcription factors, some known to shape cell fate (for example, Hmx1 and Tlx3 driving noradrenergic and cholinergic neurons, respectively), represent the most hierarchically organized class, conceptually similar to that described, for instance, for spinal cord 21, 22 ( Fig. 1e and Supplementary Fig. 1e,h) . Notably, receptor expression was also hierarchically organized, implying selective pre-ganglionic control of post-ganglionic neuron function ( Supplementary Fig. 1f,h) . Neuropeptides, which are crucial for neuronal activity modulation, exhibited specific expression profiles within neuron classes (Supplementary Fig. 1g,h) .
The in vivo existence of the predicted sympathetic neuronal types were confirmed by immunohistochemistry analyses of genes enriched in specific cell-type groups (Fig. 1g , all markers for validation are shown in Supplementary Fig. 2a-t npg a r t I C l e S soma size were analyzed ( Fig. 1h and Supplementary Fig. 2u-w) . Notably, the RET tyrosine kinase receptor protein, a known marker of cholinergic sympathetic neurons 23 , was present also in noradrenergic neurons of NA2, NA4 and NA5 types (Supplementary Fig. 2c ) and in Ret CFP reporter mice RET levels were lower in noradrenergic (Ret low TRKA + ) compared to cholinergic (Ret high TRKA − ) neurons (Fig. 1i,j) . These RET + TRKA + noradrenergic neurons of NA2, NA4 and NA5 types were defined by unique markers. NA1-NA3, but not NA4 and NA5, neurons expressed Fst, Npy and Gfra3 (GFRα3). The NA2, but not NA3, neurons expressed Htr3a and were devoid of the NA1 marker Rarres1 (Supplementary Fig. 2a-i) , whereas NA4-5 neurons expressed Gfra2 (GFRα2), Tyro3 and Cdh8 ( Supplementary  Fig. 2a-c,j-m) . NA4, but not NA5, neurons expressed Enc1 and Cntn6 ( Supplementary Fig. 2a -c,n-p).
NA2 and NA5 are erector muscle neurons Although nipple-and pilo-erection can be associated with some common stimuli, such as cold, emotional arousal and mechanical stimuli, they are clearly functionally separated, as a response in one does not necessarily result in the coincident activation of the other. This suggests the existence of unique circuits and, consistent with this, specialized cell types. We therefore focused on these sympathetic types for further insights into the mechanisms creating specificity in the sympathetic system. The RET + TRKA + noradrenergic neurons of NA2, NA4 and NA5 types appeared to be possible candidates for regulating erector muscles, as pilot experiments revealed sympathetic fibers of these organs to be both RET + and TRKA + . Organogenesis of the nipple erection muscle (NEM) and pilo-erection muscle (PEM) occurred between P1 and P3 ( Supplementary  Fig. 3a,f) . Sympathetic innervation started around P5 in both NEM and PEM ( Supplementary Fig. 3b,h ) from vessel-associated tyrosine hydroxylase (TH + ) fibers in proximity to the PEM ( Supplementary  Fig. 3g ). RET is expressed in proliferating sympathetic neuroblasts, but is downregulated concomitant with cell cycle exit and commitment to a noradrenergic fate during embryogenesis 24 . The fibers re-expressed RET by P6 ( Supplementary Fig. 3e,l) , with increasing innervation during the following week ( Supplementary  Fig. 3b,h-j) . Thus, re-expression of RET and specialization of NA2 and NA4-5 neurons coincides with organogenesis and innervation of erector muscles. We employed several strategies to directly address whether NA2 and NA4-5 neurons target erector muscles in these skin appendages. First, we found that NEM was innervated by NA2 neurons. Noradrenergic NEM fibers (TH + ) were Ret CFP+ ( Fig. 2a and Supplementary Fig. 3d ) and Dbh TOM+ fibers contained TRKA and GFRα3 ( Supplementary  Fig. 3m ). Ret mGFP+ fibers contained neuropeptide Y (NPY; Fig. 2b and Supplementary Fig. 3c ) and were Htr3a EGFP+ (Fig. 2c) . Retrograde tracing from the NEM using FastBlue (FB; Fig. 2d ,e and Supplementary Fig. 3o ,p,t) revealed that NPY + RET + NA2 neurons were labeled when traced from NEM, but not when traced from PEM ( Fig. 2e and Supplementary Fig. 3t,u) . In summary, we found that NEM is innervated by NA2 neurons (Fig. 2f) . We thereafter identified the PEM as being innervated by the sympathetic NA5 type of neurons. NA4-5 neurons were the only noradrenergic types that expressed RET and GFRα2 together. PEMs of Ret CFP mice were fully innervated by TH + Ret CFP+ fibers (Fig. 2g ) and these fibers were also Dbh TOM+ GFRα2 + (Fig. 2h ) and TRKA + (Supplementary Fig. 3n ), but did not contain NPY (Supplementary Fig. 3k ). Identification of a NA5, but not NA4, origin of PEM fibers was revealed by retrograde tracing from back-skin PEM with FB in TrkA Cre ;R26R Tomato mice. Traced cells were RET + TrkA TOM+ and GFRα2 + TrkA TOM+ , but NPY − , and therefore belonged to NA4-5 groups, and they did not express ENC1, indicating that they were NA5 neurons ( Fig. 2i-l , and Supplementary Fig. 3q-s,u) . Thus, we conclude that NEM and PEM receive innervation from unique types of sympathetic neurons (Fig. 2f,m) , which we refer to as erector muscle neurons (EMNs). However, we cannot exclude that these neuronal types also innervate other targets.
Erector muscle neurons differentiate postnatally from noradrenergic neurons RET + TRKA + (NA2, NA4, NA5) neurons were absent in early postnatal mice and differentiated postnatally, increasing in number between P5 and P11 (from 3% to 36% of all neurons), including a marked soma size increase (from 162 µm 2 at P5 to 369 µm 2 at P11 and similar in adult; Fig. 3a,b and Supplementary Fig. 4a-c) . Other noradrenergic (TRKA only+ ) neurons showed only a modest increase in soma size (from 156 µm 2 at P5 to 206 µm 2 at P11). In addition to RET re-expression and soma size expansion, differentiation also involved a postnatal onset of expression of other molecular markers (for example, FST, TYRO3 and CNTN6) predicted by single-cell RNA sequencing to define NA1-3, NA4-5 and NA4 neurons, respectively (Supplementary Fig. 4d-g ).
Thus, an intriguing aspect of EMN development is their postnatal specialization, coincident with target organogenesis, as sympathetic neurons largely exit the cell cycle during embryonic development 25 . We therefore established whether EMNs are generated during embryogenesis or born postnatally from rare proliferating neuroblasts. Sympathetic neuroblasts express Prox1 in chicken 26 . In the mouse, PROX1 was expressed throughout embryonic and postnatal development only in dividing neuroblasts, with 16% of all ISL1 + SG cells being PROX1 + at birth (Fig. 3c-e and Supplementary Fig. 4h-m) . These data indicate that new neurons are born postnatally and, consequently, could be the cellular origin of EMNs. To fate-trace proliferating PROX1 + cells, we injected 5-ethynyl-2′-deoxyuridine (EdU), which is incorporated into the DNA during cell replication, into newborn mice and collected tissue at P11 (Fig. 3f-h and Supplementary  Fig. 5a,b) . EdU + -traced cells were almost exclusively associated with TRKA + , but not EMN (RET + TRKA + ) or cholinergic (RET + ), neurons ( Fig. 3g,h) . Thus, the majority of EMNs are born during embryonic development, but specialize postnatally.
Genetic-based cell lineage tracing was performed to investigate the postnatal specialization of EMNs. A strategy based on TrkA or Ret expression for tracing noradrenergic and cholinergic neurons, respectively, was found to be feasible if traced before P5 when coexpression was only in 3% of all cells (Supplementary Fig. 4b ). Mice with tamoxifen-inducible Cre recombinase (CreERT2) controlled by the Ret promoter 27 were crossed with the Rosa26R Tomato reporter mouse strain (Ret CreERT2 ;R26R Tomato mice). Recombination specificity in cholinergic (VACHT, VIP and TLX3) neurons was confirmed by P3 injection of tamoxifen with analysis at P5 ( Supplementary  Fig. 5a ,c-f). Analysis of P11 animals, injected at P3, revealed that the vast majority of EMNs (Ret TOM+ TRKA + neurons) were not derived from cholinergic neurons ( Fig. 3i-k) . To establish whether EMNs instead originate from the noradrenergic lineage, we established a TrkA CreERT2 mouse line by homologous recombination (Supplementary Fig. 5g ) and crossed these with Rosa26R Tomato reporter mice (TrkA CreERT2 ;R26R Tomato mice). We injected control mice with tamoxifen at P3, analyzed them at P5 and found specific tracing of TRKA + noradrenergic neurons ( Supplementary Fig. 5h-j) . In mice recombined at P3 and analyzed at P11, 43% of TrkA TOM+ cells expressed RET, corresponding to more than half of all EMN a r t I C l e S neurons ( Fig. 3l-n) . Thus, the vast majority of EMNs are born during embryogenesis, remain unspecialized for a long period and differentiate postnatally from TRKA + neurons.
Unique patterns of growth factor expression in erector muscles
The notable synchronization of EMN specialization with target organogenesis suggests that differentiation is instructed by factors produced by the target. The postnatal Ret re-expression following target organogenesis is suggestive of a RET-dependent mechanism.
RET ligands interact with GDNF-family receptor-α (GFRα) members, which form a complex with the RET receptor, initiating signal transduction 28 . RNA-seq data revealed expression of Gfra3 in NA2 and Gfra2 in NA4-5 RET + TRKA + neurons (Supplementary Fig. 2c ). Immunohistochemistry confirmed expression in these neuronal types and revealed that, within all neurons of the adult SG, 39.7 ± 2.1% were RET + TRKA + and expressed GFRα2, whereas 7.0 ± 0.3% were RET + TRKA + and instead expressed GFRα3 (n = 3; see Fig. 1h for cell type proportion within groups along the rostro-caudal axis). 
npg a r t I C l e S
A detailed analysis of GFRα expression revealed different developmental processes. Although GFRα3 was already expressed in a subset of TRKA + neurons at P3 (Supplementary Fig. 6a ), GFRα2 was completely absent from noradrenergic (TH + ) neurons at P3 and instead increased as NA2 neurons differentiated between P5 and P11; thus, NA4-5 neurons required upregulation of both RET and GFRα2 (Supplementary Fig. 6b ). Essentially all Ret CFP+ GFRα3 + , but not GFRα2 + , neurons expressed NPY at P11 ( Supplementary  Fig. 6c,d) , which was previously mainly associated with vasoconstrictor SG neurons 18, 29, 30 . Given that the proportion of NPY + neurons did not change between P3 and P11 ( Supplementary Fig. 6e ), NA2 development is likely initiated by RET re-expression in a subset of already existing TH + GFRα3 + neurons. Consistent with this, the proportion of NPY + TH + neurons expressing Ret CFP increased between P3 and P11 ( Fig. 4a and Supplementary Fig. 6f,g ).
We investigated whether the targets, for example, smooth muscle cells of NEM and PEM, expressed the ligands for RET-GFRα3 and RET-GFRα2 during development using an anti-smooth muscle actin (ASMA) antibody for muscle identification. Artemin (ARTN) and neurturin (NRTN) expression in NEM and PEM, respectively, was absent at P3, initiated at P5 and increased at P11 in ASMA + cells (Fig. 4c,d) . Target innervation directly correlated with the onset of ligand expression ( Supplementary Fig. 7a,b) .
It has been shown that ARTN is expressed by ASMA + vascular smooth muscle cells of BVs and that this expression is important for guiding sympathetic axons during embryogenesis to the vicinity of target organs 31, 32 . Consistently, ASMA + BV cells of ventral skin in the prospective location of NEM at embryonic day (E) 14.5 expressed ARTN. At P1, however, vascular ARTN was markedly reduced (Fig. 4b) and was below detection at P5 and in adult mice, when Fig. 7c,d) . These results are consistent with a role for vascular ARTN in axon growth toward their target during embryogenesis, after which it is extinguished in BVs along with Ret expression in sympathetic neurons 24 . Notably, the re-expression of Ret in sympathetic neurons and expression of ARTN in NEM, and NRTN in PEM, are all events taking place once ARTN expression is downregulated in BVs, and coincides with sympathetic innervation of the target organ and by the concomitant specialization of sympathetic neurons to EMNs at postnatal stages (Fig. 4e,f) .
npg a r t I C l e S ARTN expression was upregulated in the NEM (Supplementary

Different growth factor functions in progenitors and neurons
These results may appear contradictory, as they suggest that ARTN participates in the specialization of sympathetic neurons into EMNs, yet dividing sympathetic neuroblasts are exposed to ARTN during axon growth 32, 33 without differentiating into EMNs. PROX1 activity has been shown to be necessary and sufficient for progenitor cell proliferation in several cell types, and our findings show its presence in the sympathetic neuroblasts. In an attempt to compromise proliferation to analyze the relation between cell cycle exit and neuronal specialization, we genetically eliminated Prox1. Wnt1-Cre mice carrying a Prox1 conditional mutant allele (Wnt1-Cre;Prox1 fl/fl mice) were generated for conditional deletion of Prox1 in the neural crest and all its progeny, including sympathetic neurons ( Supplementary  Fig. 8a ). Mice deficient for Prox1 had substantially fewer SG neurons at E14.5 ( Supplementary Fig. 8a,d ). Accelerated cell cycle exit and differentiation, increased apoptosis, or a decrease in cell proliferation could be underlying mechanisms. CASPASE-3 + apoptotic cells were not detected in the mutant sympathetic ganglion ( Supplementary  Fig. 8b ). However, a single EdU injection at either E13.5, E14.5 or E18.5, followed by SG analysis 2 h later, revealed a substantial decrease in the number of EdU + cells in mutant embryos at all analyzed stages and of KI67 + cells in E13.5 mutant SG (Supplementary Fig. 8c ,e,f) without any difference in the rate of cell division of cycling cells (EdU + KI67 + /KI67 + cells) (Supplementary Fig. 8g ). TRKA is a marker of differentiated cells that have exited the cell cycle and never colocalizes with PROX1 in wild-type mice. A marked increase of TRKA + cells was observed in the SG of Wnt1-Cre;Prox1 fl/fl embryos at E14.5 and E18.5 ( Fig. 5a and Supplementary Fig. 8h ), which is indicative of premature cell cycle exit and progenitor differentiation into noradrenergic neurons. Notably, an increased number of prospective RET + TRKA + EMNs was observed at both E14.5 and E18.5 (Fig. 5b,  Supplementary Fig. 8j,k) . These may truly represent precociously differentiated EMNs, as the soma size of the TRKA + neurons at E18.5 was markedly larger than in control mice (Supplementary Fig. 8l ).
Given that ARTN, but not NRTN, is expressed by BVs at E14.5, we predicted these to be NEM neurons. We therefore assessed the proportion of TH + RET + NPY + (NEM neurons) or TH + RET + NPY − (PEM neurons) in the Prox1-deficient SG. Although the total number of NPY + cells was not affected at either E14.5 or E18.5 in Wnt1-Cre;Prox1 fl/fl embryos (Supplementary Fig. 8m ), the proportion of TH + RET + NPY + neurons was significantly increased in mutant embryos at E18.5 compared with controls, accounting for nearly half of all precocious EMNs ( Fig. 5c and Supplementary Fig. 8i ). We therefore conclude that neuroblasts exit the cell cycle precociously in the Wnt1-Cre;Prox1 fl/fl mice. Because of this, an exposure of neurons instead of neuroblasts to vesselproduced ARTN could underlie an induction or maintenance of RET expression. If so, this may explain why EMN differentiation is prematurely activated in embryonic neurons of Prox1-deficient mice.
Thus, growth factor exposure after cell cycle exit could drive specialization of TRKA + neurons into EMNs. In this case, artificial exposure to ARTN or NTRN should induce precocious RET expression in TRKA + neurons. Thoracic ganglia from newborn Wnt1-Cre;R26R Tomato mice cultured as explants with ARTN, NRTN or nerve growth factor (NGF) for 24 h had a significant increase of RET + TH + neurons (Fig. 5d,e and Supplementary Fig. 8n) . No difference in apopototic (TH + CASP3 + ) cells was seen between the conditions (Supplementary Fig. 8o,p) . Thus, it is possible that NGF exposure may initiate RET expression in postmitotic neurons, which in turn reinforces its own expression, thereby consolidating a RET + TRKA + EMN fate.
RET and GFR2 contribute to erector neuron differentiation To address a possible in vivo participation of RET signaling in differentiation and target innervation of EMNs, we first examined Retdeficient mice. However, Ret full knockouts die perinatally 34 . To circumvent this, and to specifically delete Ret in TRKA + sympathetic neurons, we generated TrkA Cre/+ ;Ret fl/fl mice. In these mice, the Ret alleles are flanked by loxP sites 35 . Thus, these mice express Ret normally until TrkA expression is initiated in sympathetic neurons. Ret is thus deleted after cell migration, axonal extension and cell cycle exit of Prox1 neuroblasts. Hence, analysis of this strain should be useful to ascertain the role of RET specifically for development of EMNs and target innervation, independent of its functions in early development. We confirmed that RET was selectively eliminated in TRKA + neurons of these mice (Supplementary Fig. 9c ). Innervation of both the NEM and PEM was significantly reduced in these conditional Ret-deficient mice (Fig. 5f,g,i,j and Supplementary Fig. 9a,b) as well as in the PEM of co-receptor GFRα2 null mice (Gfra2 KO/KO mice; Fig. 5h,k) . Differentiation of EMNs was also affected in both RET-and GFRα2-deficient mice with deficits of soma size growth of EMNs, without effects on the number of neurons formed at P11 (Fig. 5l-q) . Thus, our results indicate that RET and GFRα2 participate in both EMN target innervation and differentiation, suggesting that GDNF family ligands drive these processes.
DISCUSSION
For decades, the complexity of the sympathetic nervous system has represented a challenge, and cell types were mostly characterized by physiological features and the presence or absence of a restricted cohort of molecular markers. Using unbiased classification based on single-cell RNA profiling of cells, our results provide evidence for molecularly distinct types of sympathetic neurons, which fits the idea that the sympathetic nervous system is optimally adapted to appropriate output depending on the target 15 .
We identified seven types of autonomic neurons in the thoracic sympathetic chain, including two types of cholinergic neurons (ACh1, ACh2) based on expression of Slc18a3 (VACHT) and five noradrenergic groups, as defined by expression of TH, dopamine-β-hydroxylase (DBH) and TRKA. Cholinergic sympathetic neurons have previously been characterized by expression of RET, VIP, TLX3, CHAT and VACHT. Consistently, both ACh1 and ACh2 cholinergic types express all these markers. However, each group also displays a unique molecular profile. ACh1 neurons have abundant levels of CCK-B receptor (Cckbr), G-protein-coupled receptor (Gpr115) and the high-affinity choline transporter for acetylcholine synthesis (Slc5a7), whereas ACh2 neurons are enriched for the angiotensin receptor (AGTR2) and somatostatin (SST). Sweat glands and periosteum are innervated by cholinergic neurons 36, 37 . The existence of two discrete cholinergic neuron types suggests the existence of two unique cholinergic circuits. Most cholinergic neurons of the stellate ganglia, which innervate sweat glands, are VACHT + SST − . Based on this, we propose that SST − ACh1 npg a r t I C l e S neurons could innervate sudomotor targets, whereas SST + ACh2 neurons of the thoracic ganglia innervate the periosteum. Among noradrenergic sympathetic neurons, we identified the NA2 and NA5 classes of large neurons as EMNs. Future studies will be needed to uncover the function of the remaining three identified neuronal types. Previous studies have reported that around 50% of the sympathetic ganglion is made of small-size NPY + sympathetic neurons that innervate smooth muscle of BVs, regulating vasculature tone 18, 38 . The NA3 class of neurons that we identified is the most numerous in neuronal numbers, has small soma size and contains NPY, thus representing a strong candidate for this function.
The sympathetic neuron fate is initiated by a regulatory network of transcription factors 39 defining a common noradrenergic-cholinergic sympathetic progenitor 24 . This hybrid progenitor diversifies to noradrenergic and cholinergic sympathetic types via processes that are regulated by the expression of the transcription factors HMX1 and TLX3, respectively 24, 40 . At the same time, HMX1 also extinguishes neuroblast expression of RET during neuronal commitment 24 . Our results show that this initial segregation of noradrenergic and cholinergic fates is only the beginning of the assembly of neuronal circuits. The identified hierarchically organized transcription factors could participate in further diversification to reach the neuronal variety observed in the adult.
We found that erector muscles are controlled by dedicated neurons with unique molecular profiles represented by NA2 and NA5 neurons. This allowed us to address the mechanisms driving specialization. Our results are consistent with the idea that neuroblasts send out axons and navigate along BVs in response to ARTN embryonically 31, 32 ; thereafter they exit the cell cycle, but remain as unspecialized neurons until postnatal stages, when organogenesis of the targets occurs. Initiation of EMN specialization is defined by RET re-expression, which appears to be a complex mechanism and could involve redundant functions of both TRKA signaling as well as a RET-dependent auto-regulatory loop, as we found that activation of any of these pathways induced RET re-expression. In line with these results, the premature cell cycle exit in Wnt1-Cre;Prox1 fl/fl mice results in maintained RET expression and increased commitment to NEM neurons, consistent with an unscheduled exposure of differentiated neurons, instead of neuroblasts, to ARTN from BVs. Thus, although both NGF and GDNF family ligands were found to be sufficient for RET induction, it remains unclear whether they are required in vivo. We therefore cannot exclude the notion that the concomitant upregulation of ligands at the target and neuronal RET re-expression are independently regulated events.
Once RET expression was re-initiated postnatally, we found that soma cell expansion of EMNs and organ innervation required the functional activity of RET as well as the NRTN co-receptor GFRα2. RET and RET co-receptors are important for somatic motor neuron nerve attraction and pathfinding involving a synergistic function between RET ligands, GFRα and Ephrin A reverse signaling integrated by RET 41 , as well as RET independent signaling by GFRα through NCAM 42 . Our results favor a GDNF-family-ligand-mediated mechanism because the target and soma size deficit was similar between RET-and GFRα2-deficient mice, which would not be the case for an Ephrin-A-reverse-or NCAM-dependent mechanism. However, axon guidance and target innervation is nevertheless clearly a complex process that extends beyond the GDNF-ligand-GFRα-RET pathway. Further complexity could be caused by the fact that axons might never reach the source of the differentiation signals required for normal EMN specification in Ret mutants. However, as the innervation deficit is partial, such a mechanism would result in a bimodal distribution of EMN soma size in the Ret mutant mice, with neurons innervating the target displaying normal size and neurons failing target innervation with reduced size. In contrast, a direct dependence on RET would result in a failure of soma size growth in all neurons, including those successfully innervating the target in the absence of RET. As the distribution of soma size appeared to be unimodal in TrkA Cre/+ ;Ret fl/fl mice (Supplementary Fig. 9d) , a direct role of GDNF ligands on differentiation seems likely (Fig. 5r,s and Supplementary Fig. 10 ).
In conclusion, our results reveal an unanticipated cellular diversity underlying autonomic functions, the existence of dedicated EMNs and provide insights into the mechanisms by which they are formed. Thus, we believe that our results provide the cellular framework for a functional organization of circuits that could underlie the specificity of diverse autonomic functions.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Accession codes. All raw data is deposited at NCBI Gene Expression Omnibus accession number GSE78845. Bayesian regression results for all genes expressed in the different neuronal types are available for download at http://linnarssonlab.org/sympathetic/. Plots for any gene or group of genes can be visualized at the same address. CreERT2 (background not known), mice have been described previously 27, 35, [43] [44] [45] [46] [47] [48] . TrkA CreERT2 mice were generated as follows: the IRES-CreERT2-pA vector was inserted into the 17 th exon of the Ntrk1 (TrkA) gene, to allow co-expression of an inducible Cre from this locus (Supplementary Fig. 5g ). The targeting vector was designed based on genomic sequence data obtained from Ensemble Mouse Genome Server and consisted of 5′ and 3′ homology arms (5H and 3H, respectively) generated by PCR from C57BL/6 genomic DNA, an IRES-CreERT2 arm with a polyadenylation fragment (pA) and a FRT-flanked PGK-Neo positive selection cassette. The targeting vector was linearized by AscI digestion before electroporation into ES cells. Upon Neomycin selection of cells bearing the vector, the 5′ probe was used for detection of correct targeting by Southern hybridization, the 3′ probe was used for detection of the changes to the targeted locus with FLPe-mediated deletion and the Neo probe was used to detect bands due to additional random integrations of the targeting construct. Compatible ES cells were injected in 3.5-dpc blastocysts to generate chimeric TrkA CreERT2 mice. Chimeric mice were bred to C57BL/6 females to generate heterozygous mice carrying the targeted allele. Removal of the neo cassette was performed by breeding TrkA CreERT2 heterozygous mice to FlpE mice. Genotyping of TrkA CreERT2 mice was performed by PCR. To detect the Cre allele, the following primers were used: 5′-ACCAGGTTCGTTCACTCATGG-3′ (Forward) and 5′-AGGCTAAGTGC CTTCTCTACA′ 3 (Reverse), which gave a band of 200 bp. To detect the wildtype allele, the following primers were used: 5′-GGACCAAAATGGAAATTGA-3′ (Forward) and 5′-CCTGCCCTCCTGATGTCTAC-3′ (Reverse), which gave a band of 499 bp. Animals were group-housed, with food and water ad libitum, under 12-h light-dark cycle conditions. All animal work was performed in accordance with the national guidelines and approved by the local ethics committee of Stockholm, Stockholms Norra djurförsöksetiska nämnd. Animals were sacrificed when reaching a score of 0.3 on Karolinska Institute's extended health assessment list.
Tissue preparation. Embryos and adult mice of mixed background were used in this study. For embryo staging, the day that the plug was detected was considered as embryonic day (E) 0.5; for postnatal staging, the day when the mice were born was considered to be P0. Briefly, samples were immersion fixed in 4% paraformaldehyde (PFA, Roth, #P087.3) in PBS (pH 7.4) at 4 °C for 2-5 h, depending on the experimental stage. Embryos were generally kept in PFA for 2-4 h; single dissected ganglia of fluorescent mice used for immunohistochemistry were fixed for 0.5-2 h, depending on the developmental stage. When P3-11 animals were used, the entire thoracic chain of sympathetic ganglia was dissected out together with the spine and fixed for at least 5 h, after complete removal of the internal organs, to facilitate PFA tissue penetration. Skin appendage samples of hair arrector pili and mammary papilla were fixed for 5 h. All samples were then washed in PBS at 20-25 °C for 1 h, then cryo-protected by immersion in 30% sucrose in PBS, at 4 °C, overnight. Tissues were then embedded in OCT, snap frozen and then stored at −20 °C, then cut in 14-20-µm-thick sections, collected on series of 6-12 slides and conserved at −20 °C until use. dissection of thoracic Sg. SG are small and hardly distinguishable from the surrounding tissues. For this reason, R26R Tomato mice were crossed to the Wnt1-Cre, Dbh Cre or TrkA Cre mice to achieve recombination of the reporter protein in all neural-crest-derived structures (Wnt1-Cre;R26R Tomato mice), restricted to autonomic neurons (Dbh Cre ;R26R Tomato mice) or to noradrenergic neurons (TrkA Cre ;R26R Tomato mice), thus making them visible. Dissection was carried out using a stereotactic microscope equipped with a fluorescent light source. Wnt1-Cre;R26R Tomato mice were used for single cell experiments and for retrograde tracing from the NEM (Fig. 2d,e and Supplementary Fig. 3o,p,t) ; Dbh Cre ;R26R Tomato mice were used for quantification of the proportion of sympathetic cell types and their soma area (Fig. 1g,h and Supplementary Fig. 2u-w) ; TrkA Cre ;R26R Tomato mice were used for retrograde tracing from the PEM (Fig. 2i-l and Supplementary Fig. 3q,s,u) Fig. 2 and Supplementary Figs. 2 and 3) . ganglia dissociation for single cell analyses. Five Pasteur pipettes were flamed to gain smooth tips of different diameters (from approximately 70% to 10% of the original opening). The pipettes were then coated with 0.5% BSA solution for at least 1h at RT. 17 male and female Wnt1-Cre;R26R TOM/+ mice were sacrificed at 27-35 d of age (P27-35) and the thoracic sympathetic ganglia (including the stellate ganglion and the ganglia at thoracic levels 1-12, SGs) were collected in freshly oxygenated artificial cerebral spinal fluid (ACSF) 19 kept on ice. The SG were transferred into a 3-cm plastic dish containing 2.7 ml of pre-heated (37 °C) digestion solution. The digestion solution consisted of 500 µl TrypLE Express (Life Technologies; #12605-010), 2,000 µl Papain solution (Worthington Biochemical; #LK003178; 25 U ml −1 in ACSF), 100 µl DNAse I (Worthington Biochemical; #LK003172; 1 mM in ACSF) and 100 µl Collagenase-Dispase (Roche; cat#11097113001; 20 mg ml −1 in ACSF). SGs were mechanically triturated every 30 min using the different glass pasteur pipettes starting with the biggest diameter. After 1h incubation at 37 °C, 100 µl of fresh Collagenase-Dispase (20 mg ml −1 ) solution was added. In addition, fine forceps were used to remove SG meninges and make cells more accessible for the enzymes. Bigger tissue debris was removed if possible. After another 1-h incubation at 37 °C, single cells started to become visible. If necessary additional 50 µl of Collagenase-Dispase (20 mg ml −1 ) and 100 µl of TrypLE solution were added and theincubation as well as trituration was prolonged until single cells could be seen. The suspension was then filtered using a 40-µm cell strainer (FALCON, # 352340) and collected in a 15-ml plastic tube. The digestion solution was diluted in 3 ml ACSF and centrifuged at 100g for 4 min at 4 °C. The supernatant was removed and the pellet resuspended in 0.5 ml ACSF and 0.5 mL Neurobasal-A medium (Gibco; #10888). Neurobasal-A medium was supplemented with L-Glutamine (Gibco; #25030-123), B27 (Gibco, #17504-044) and penicillin-streptomycin (Sigma 50×, #P4458). The cell suspension was carefully transferred with a Pasteur pipette onto an Optiprep gradient composed of 80 µl of Optiprep Density Solution (Sigma; #D1556), 460 µl of ACSF and 460 µl Neurobasal media with supplements. The gradient was then centrifuged at 100g for 10 min at 4 °C and the solution concentrated to 100 µl by removing the supernatant. 10 µl of DNaseI was added to avoid cell clustering. Cell density was evaluated and adjusted to a concentration of 400-500 cells µl −1 .
Single cell analysis. Fluidigm C1 Autoprep System microfluidic chip (medium size) was used to capture the cells as described previously 19 . Both bright field and fluorescent reporter imaging was performed on a Nikon TE2000E automated microscope. The images of the capture sites were inspected by an operator and only single healthy cells were selected for library preparation.
Cell barcoding and fragmentation were performed in a single step using Tn5 DNA transposase (tagmentation) as described previously 19 , but using a different Binding and Blocking buffer (10 mM Tris, 250 mM NalCl, 5 mM EDTA, 0.5% SDS).
The molar concentration of the libraries was determined with KAPA Library Quant qPCR (Kapa Biosystems) and size distribution was evaluated after PCR (12 cycles) using Agilent BioAnalyzer. Sequencing was performed on an Illumina HiSeq 2000 and reads were mapped using bowtie and processed as described previously 19 , but adding a more strict criterium for unique molecular identifier (UMI) counting, which consisted in removing all singletons (molecules supported by only a single read, eg one UMI). All raw data is deposited at NCBI Gene Expression Omnibus accession number GSE78845.
To exclude broken and undetected doublet cells from the analysis the distribution of molecules per cell was examined in each data set and a lower and an upper threshold (1,500-85,000 molecules per cell) was set. Cells outside of this range, as well as non-neuronal cells, were excluded. In addition, genes that were detected at less than 4 molecules in the whole data sets were eliminated. A total of 298 neurons passed the criteria and were included in the analysis, with an amount of detected transcripts between 7,226 and 81,596 (median: 33,103).
Feature selection was performed before clustering. Genes were scored and sorted by the difference between the observed coefficient of variation (CV) and the CV predicted by a nonlinear noise model learned from the data and the top ranking 400 genes were chosen. The model was fit using Support Vector Regression (SVR) 49 (scikit-learn python implementation, default parameters with gamma = 0.1) 50 . Genes whose expression was significantly higher (P < 0.001) in the excluded non-neuronal populations were excluded from the analysis to avoid background noise due to potential cross-contamination events. To cluster the cells we used the backSPIN algorithm as previously described (with parameters numlevels = 4, first_run_iters = 15, first_run_step = 0.1, runs_iters = 12, runs_step = 0.1, stop_const = 1.1) 19 . However, here, when attributing genes after a split we used the center of mass E[ix i ] instead of the mean.
E ix ix
Briefly, the two halves of the main matrix are considered in the orientation that maximizes the distance of their center of mass E[ix i ] from the point of split. Then, the center of mass over the parent matrix is calculated and the genes are assigned to the cluster of cells that contains the center of mass.
When calling cell clusters, a conservative approach was preferred in order to avoid unnecessary splits. In case the splits within a clustered matrix did not show strong differences, we rejected the splits and reconstituted the parent cluster. Furthermore, a group characterized by low quality data was excluded from further analysis.
To visualize the high dimensional data in a two-dimensional space and to validate our clustering result we used t-distributed stochastic neighbor embedding (t-SNE scikit-learn implementation 20 , early_exaggeration = 4, perplexity = 40, learning_rate = 100). As a fair comparison, we calculated t-SNE projection (Fig. 1c) using the same genes that were used as initial input in the backSPIN algorithm. t-SNE is a nonlinear dimensionality reduction algorithm similar in purpose to principal component analysis (PCA). The aim is to transform multidimensional data so that it can be visualized as a two dimensional plot. Specifically, on a t-SNE plot two similar cells are represented by nearby points and dissimilar cells by distant points. t-SNE performs exceptionally well with single-cell data and has therefore been widely adopted in the single-cell RNA-sequencing field.
Similarities between clusters were summarized using Pearsons's correlation coefficient (Fig. 1d) calculated on the binarized matrix (see below). For the calculation, all genes that scored significant over the baseline level of expression in at least one of the clusters were used. Genes which were detected at less than 1 molecule per cell in all the clusters were excluded from the calculation. Correlation matrix was then sorted using hierarchical clustering 51 . We used a Bayesian generalized linear model (GLM) to determine posterior probability distribution for the expression of every gene, deconvolving cell-type-specific gene expression (cell type coefficient) from the basal level of expression (baseline coefficient). A more detailed formulation of the model, including prior probability distribution, is provided elsewhere 19 . To determine which genes are higher than baseline expression in each group, we compared the posterior probability distributions of the baseline coefficient and the cell type coefficient. Within sympathetic cell groups, genes were considered to be expressed over the baseline if (I) their class-specific coefficient exceeded 25% of the baseline coefficient with 99% posterior probability and (II) if the median of their posterior distribution did not fall below a threshold set to 20% of the median posterior probability of the highest expressing group. For every gene this corresponds to a binary pattern (0 if the conditions are not met and 1 if they are) and genes can therefore be grouped according to their binarized expression patterns. We used these binarized pattern to give a simplified description of the complex molecules patterns of Figure 1e and Supplementary Figure 1e -g. Our definitions of neuropeptide, transcription factor and receptor gene are based on annotations provided by PANTHER GO 52 .
A similar posterior probability based approach was used to provide a finer binning, by including information regarding high and a low level of expression for the genes constituting the main markers and for those used for validating the model (Fig. 1f and Supplementary Fig. 2c ). The following criteria were used: (I) the class-specific coefficient must exceed 15% of the baseline coefficient with 97.5% posterior probability and (II) for the "low" and "high" level of expression the threshold was set to 15% and 50% the median of the highest expressing group respectively. In Supplementary Table 3 genes are shown that satisfied the following three conditions: (I) gene expression must be above baseline with >99% posterior probability only for the cell type considered; (II) gene expression must be more than 1.8 times higher in the highest cell type compared to the second highest; and (III) the difference to the second highest cell type must be of more than 0.75 mRNA molecules. These thresholds were applied to the regressionestimated expression levels, not the raw molecule counts.
ganglia dissociation for quantification of the identified sympathetic types. The superior cervical ganglion (SCG), stellate ganglion, and sympathetic chain ganglia from thoracic levels 1-4 and 5-12 from 3 adult Dbh Cre ;R26R Tomato were collected and interrogated for the presence and abundance of the identified seven classes of sympathetic neurons and for their soma size. The number of averaged cells for soma size calculation was 51 for NA1 neurons from the stellate ganglion and 74 for NA2, 97 for NA3, 76 for NA4, 104 for NA5, 77 for ACh1 and 84 for ACh2, from thoracic (tho) 1-4 and tho 5-12 ganglia.
Retrograde axonal tracing experiments. For PEM retrograde tracing, TrkA Cre ;R26R Tomato males and females and Wnt1-Cre;R26R Tomato females mice were used. FB (Polisciences, #17740-1) was reconstituted as a 2% solution in distilled water and was delivered in the target organ of adult mice using a 5-µl Hamilton syringe (Hamilton, #65460-02). During the procedure, animals were kept anaesthetized with isofluorane (Baxter, # KDG9623) in oxygen-enriched air. For PEM tracing, a total of 2 µl of FastBlue (~0.25 µl per injection, eight injections per animal) was injected intradermally, along the dorsal midline of each animal. Each injection site was distanced from the next by ~2 mm. For NEM tracing, the six thoracic nipples were injected once delivering ~0.25 µl of FB (for a total of a total of 1.5 µl per animal). Recovering mice were sacrificed 6 d later and fluorescent SG were dissected and rapidly fixed in 4% PFA in water for 2 h at 4 °C, then moved to 30% sucrose in PBS for cryoprotection, overnight at 4 °C. The day after, ganglia were embedded in Tissue-Tek and 16-µm-thick sections were collected on a series of eight slides, dried for at least 1 h at 20-25 °C and stored at −20 °C until used.
cell fate tracing experiments. R26R Tomato mice were crossed to the TrkA CreERT2 and Ret CreERT2 mice to generate TrkA CreERT2/+ ;R26R Tomato/+ and Ret CreERT2/+ ; R26R Tomato/+ mice for cell fate tracing of noradrenergic and cholinergic postnatal sympathetic neurons, respectively. Tamoxifen (Sigma, #T5648-1G) was dissolved in corn oil (Sigma, #8267) and delivered via intra peritoneal (i.p.) injection to pregnant females and pups (0.1 mg g −1 , body weight). For 5-ethynyl-2'-deoxyuridine (EdU) experiments, EdU (Thermo Fisher Scientific, #E10187) was dissolved in PBS at the concentration of 6.5 mg ml −1 , filtered using a 22 µm filter, and injected i.p. in wild-type pregnant dams or pups (10 µl g −1 body weight). 
